Date: March 27, 2026 Focus: HBM supply positioning for Nvidia/AMD next-gen chips, cyclical framework, and lessons from prior memory cycles Table of Contents 1. Executive Summary 2. The Business: What You're Actually Buying 3. Financial Comparison: The P&L 4. HBM: The Battle for Nvidia and
March 2026 | ~19p | Market Cap ~£190m ($240m) | ~978m shares outstanding 52-Week Range: 4.7p – 21.8p | FY2025 Revenue: ~£97m Executive Summary IQE is the world's leading pure-play outsourced epitaxial wafer manufacturer for compound semiconductors. The company sits at one of the most technically demanding and strategically critical steps
As of March 2026 Table of Contents 1. Executive Summary 2. Epidemiology 3. Market Size & Forecasts 4. Diagnosis & Staging 5. Current Treatment Landscape by Line of Therapy 6. R&D Pipeline: Drugs in Active Development 7. The KRAS Revolution 8. Novel Modalities & Emerging Approaches 9. Unmet
PolyNovo (ASX: PNV) — Sharp Take (Bearish) March 2026 | ~A$0.92 | ~A$636M market cap What Is This Thing PolyNovo is an Australian medical device company that makes a single meaningful product: NovoSorb BTM (Biodegradable Temporising Matrix), a synthetic polyurethane foam scaffold used for dermal regeneration in burns and complex
The Short Answer Yes, but Credo knows it and is pivoting. The threat is real at the physics level — copper has a hard distance and bandwidth ceiling that optical does not. But the timeline gives Credo a multi-year runway, and the company is aggressively building an optical product line to
MARCUS WEBB (Macro-Focused Value Manager, Multi-Asset Fund): So we're sitting here the night before what's probably the most watched earnings print of the year, and I think the first question we have to ask ourselves is whether this is actually an interesting setup or whether the
Sarah: Mike, thanks for doing this. The cybersecurity sector is in an incredibly interesting place right now. We've got the biggest M&A wave in the history of the industry, AI reshaping both the threat landscape and the defense stack, and a broad tech selloff pulling down
NASDAQ: DAVE Market Cap: ~$2.3B | Price: ~$165 | P/E: ~16x Analyst A (Skeptic): DAVE has been one of the best-performing stocks of the past two years - up something like 3,000%+ from its 2023 lows. Everyone on fintwit loves it. The numbers look great on the surface. But
Pod Shop Debate Market Cap: ~$600M | Price: ~$4.40 | Pre-Feasibility Stage Analyst A (Skeptic): Alright, let's tear into this one. ABAT is getting a lot of retail love - the stock doubled in a month recently - but I think the story has more holes than a lithium-bearing
BEAR: Alright, stock’s down 8% after hours on a beat. The market’s telling you something. BULL: The market’s telling me it had unrealistic expectations. $10.27 billion in revenue, 34% growth, record EPS—and the guide came in above Street. What exactly disappointed here? BEAR: The trajectory.
The Laser Behind the AI Boom: Lumentum's $400 Stock or Coming Correction? Executive Summary Lumentum Holdings (NASDAQ: LITE) has emerged as a critical infrastructure play in the AI datacentre buildout, with its stock surging over 350% from $87 in November 2024 to approximately $422 as of February 2026.
Sarah Chen (Bull): Alright, the stock's down 10% after hours and I know you're sharpening your knives, Marcus. But before you start dancing on what you think is a grave, let me explain why this is a gift. For anyone who needs the refresher: ServiceNow is
Sarah Bull: Alright Marcus, I know you've been itching to tear this one apart, but hear me out first. For anyone who hasn't done the work on GRAIL — and I know you have, Marcus, despite pretending you haven't built a 47-tab spreadsheet on this